Atlas Trials

A Study to Evaluate the Use of Apremilast in Patients With Psoriatic Arthritis, Naïve to Biological Treatment

Clinical trial NCT03828045 · COMPLETED

Trial details

NCT number
NCT03828045
Sponsor
Amgen
Status
COMPLETED
Study type
OBSERVATIONAL
Arthritis, Psoriatic
Start date
2019-02-06
Primary completion
2021-10-20
Enrollment
119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.